Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection

Clinical trial NCT06934070 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06934070
Sponsor: Qiang Xu
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC) Prognosis

Start date: 2025-04-03
Primary completion: 2025-04-03
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.